City

Barcelona (1)

Madrid (1)

Paris (1)

Valencia (1)

Condition

Breast Neoplasms (1)

Carcinoma, Endometrioid (1)

mTOR Protein (1)

mTor Protein (1)

Overall Status

Completed (2)

Phase

phase 2 (2)

Sponsor

ARCAGY/ GINECO GROUP (1)

MedSIR (1)

Collaborator

Novartis (1)

Intervention

everolimus (1)

tamoxifen (1)

temsirolimus (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Other (2)

Study Type

Interventional (2)

mtor protein

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Carcinoma, Endometrioid, mTOR Protein Trial in Barcelona, Madrid, Valencia (Temsirolimus)

Completed

Carcinoma, Endometrioid
mTOR Protein

Temsirolimus

Barcelona, Spain
+2 more

Nov 25, 2020

Breast Tumors, mTor Protein Trial in Paris (Tamoxifen, Everolimus)

Completed

Breast Neoplasms
mTor Protein

Tamoxifen
Everolimus

Paris, France

Hopital Hotel Dieu

Nov 7, 2018